Board approves a 5-year re-appointment of MD Ashish Puravankara from April 2026, and a merger of two wholly owned subsidiaries; unaudited quarterly and nine-month results for Dec 31, 2025 to be reviewed; postal ballot for shareholder approval.
AI Assistant
Puravankara Ltd
2026
Announcement
Find Answers
Ask about any part of the document to get insights, explanations, or key details.